Therapeutic targets for neuroprotection in acute ischemic stroke: lost in translation?
about
Potential therapeutic effects of neurotrophins for acute and chronic neurological diseasesPhotothrombosis-induced infarction of the mouse cerebral cortex is not affected by the Nrf2-activator sulforaphaneA novel mechanism for cytoprotection against hypoxic injury: δ-opioid receptor-mediated increase in Nrf2 translocationNeuroinflammation and cerebrovascular disease in old age: a translational medicine perspectiveThe science of cerebral ischemia and the quest for neuroprotection: navigating past failure to future successTherapeutic time window and dose dependence of xenon delivered via echogenic liposomes for neuroprotection in stroke.Imidazol-1-ylethylindazole voltage-gated sodium channel ligands are neuroprotective during optic neuritis in a mouse model of multiple sclerosis.Calcium-sensing receptor (CaSR) as a novel target for ischemic neuroprotection.Enriched Endogenous Omega-3 Polyunsaturated Fatty Acids Protect Cortical Neurons from Experimental Ischemic Injury.Low-frequency rTMS in patients with subacute ischemic stroke: clinical evaluation of short and long-term outcomes and neurophysiological assessment of cortical excitability.Exploring the role of MKK7 in excitotoxicity and cerebral ischemia: a novel pharmacological strategy against brain injury.The interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseases.Protection against Oxygen-Glucose Deprivation/Reperfusion Injury in Cortical Neurons by Combining Omega-3 Polyunsaturated Acid with Lyciumbarbarum PolysaccharideSuccessfully Climbing the "STAIRs": Surmounting Failed Translation of Experimental Ischemic Stroke Treatments.Prognostic value of inflammatory mediators in 1-year outcome of acute ischemic stroke with middle cerebral artery stenosis.Neuroprotection in stroke: past, present, and future.Selective 14-3-3γ induction quenches p-β-catenin Ser37/Bax-enhanced cell death in cerebral cortical neurons during ischemia.Neuroprotection against hypoxia/ischemia: δ-opioid receptor-mediated cellular/molecular events.Current Neurogenic and Neuroprotective Strategies to Prevent and Treat Neurodegenerative and Neuropsychiatric Disorders.Vectorized nanodelivery systems for ischemic stroke: a concept and a need.Current and future perspectives on the treatment of cerebral ischemia.Patient-specific pluripotent stem cells in neurological diseases.NOX4-dependent neuronal autotoxicity and BBB breakdown explain the superior sensitivity of the brain to ischemic damage.Erythropoietin activates Keap1-Nrf2/ARE pathway in rat brain after ischemia.mfat-1 transgene protects cultured adult neural stem cells against cobalt chloride-mediated hypoxic injury by activating Nrf2/ARE pathways.Endovascular Reperfusion and Cooling in Cerebral Acute Ischemia (ReCCLAIM I).The Combination of Human Urinary Kallidinogenase and Mild Hypothermia Protects Adult Rats Against Hypoxic-Ischemic Encephalopathy-Induced Injury by Promoting Angiogenesis and Regeneration
P2860
Q26827281-9B18BA3E-A0D3-4A29-9277-234820773874Q28386693-5577B097-4D5B-4356-9A33-6B7459FF041CQ28390721-972FFBF0-D940-494F-8C3B-1272B7A34D6FQ28393202-91C2ECA9-1D5E-4F6D-96F5-8E01E5CD1A5BQ28394257-EA9D40EF-FC05-4281-A35C-8DA0F46C5886Q30429580-A6DDB858-B346-47E1-B674-380329188C07Q33568213-49A768E5-33CB-43C7-AFAF-8D14D833F624Q34455700-17D0F5F5-90E3-4FFB-AD1A-182FE5E24527Q35854060-1EA11DC8-38D1-4D96-BFF7-C88CEA577599Q36017727-DD0A136A-89ED-448D-A196-A725E8A9FD39Q36022319-3E37032F-EED4-48E3-8727-E434AA2F4844Q36342106-48E4A77C-E404-4D9E-8C1E-2F1C6999C407Q36507510-04763F51-EAD1-49C1-A53C-200DE8672AAAQ36530228-F21D3CC1-01BE-4660-A30B-DF8AF9FE304EQ37139691-D2CABD58-A6E4-40C6-98CC-C4B395FDB289Q37571562-1D2E0C3D-F702-4D1C-A873-3D815BE0D62FQ37726133-E455296D-56CE-4B34-875F-018682C506A0Q38046756-71CCC86F-50BD-4582-A177-CC4FBB894A50Q38587566-991E7D8B-494F-4BFF-9B03-2D83A789909EQ38731765-1600D9E7-367B-48D7-BFB9-3D3F92ABDFAAQ38732640-EC052C52-094B-45E2-85FB-85981A1B8899Q41836711-6634D40F-7E98-44FD-8C66-72E23E0BE395Q42503323-083D7497-4472-488B-AF2B-CE845EA4E7E2Q44992435-7777A44E-F229-4B38-A35C-38F19F5B7D73Q46346288-503E195B-74EF-4102-B44F-40B8EA00C076Q48136167-74D77662-740A-47DA-ACD7-93543B6967F5Q58828687-3BB33D32-CF60-46D3-8E91-012D3AE2963B
P2860
Therapeutic targets for neuroprotection in acute ischemic stroke: lost in translation?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Therapeutic targets for neuroprotection in acute ischemic stroke: lost in translation?
@en
Therapeutic targets for neuroprotection in acute ischemic stroke: lost in translation?
@nl
type
label
Therapeutic targets for neuroprotection in acute ischemic stroke: lost in translation?
@en
Therapeutic targets for neuroprotection in acute ischemic stroke: lost in translation?
@nl
prefLabel
Therapeutic targets for neuroprotection in acute ischemic stroke: lost in translation?
@en
Therapeutic targets for neuroprotection in acute ischemic stroke: lost in translation?
@nl
P2860
P356
P1476
Therapeutic targets for neuroprotection in acute ischemic stroke: lost in translation?
@en
P2093
Jeannette N Stankowski
Rishi Gupta
P2860
P304
P356
10.1089/ARS.2010.3292
P577
2010-10-25T00:00:00Z